Dr. Reddy's Laboratories
222 hedge funds and large institutions have $1.84B invested in Dr. Reddy's Laboratories in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 91 increasing their positions, 69 reducing their positions, and 31 closing their positions.
453% more call options, than puts
Call options by funds: $1.18M | Put options by funds: $213K
32% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 69
6% more capital invested
Capital invested by funds: $1.73B → $1.84B (+$106M)
1.51% more ownership
Funds ownership: 70.81% → 72.32% (+1.5%)
4% less funds holding
Funds holding: 231 → 222 (-9)
19% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 31
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$82.6M |
| 2 |
JP Morgan Chase
New York
|
+$27.1M |
| 3 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$20.3M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$15M |
| 5 |
Jane Street
New York
|
+$12.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
-$41.9M |
| 2 |
Goldman Sachs
New York
|
-$41.3M |
| 3 |
BlackRock
New York
|
-$27M |
| 4 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$12.4M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$7.8M |
RDY Hedge Fund Activity: Q2 2024 in Review
222 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2024, worth a combined $1.84B — up 6.1% from $1.73B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of RDY and 25 opened new positions — a net loss of 6 holders — while 69 trimmed existing stakes and 91 added.
The largest buyer was Morgan Stanley, adding an estimated $82.6M. The largest seller was Man Group, cutting an estimated $41.9M.
- 222 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2024, down from 231 in Q1 2024.
- Funds reported $1.84B of Dr. Reddy's Laboratories stock for Q2 2024, up 6.1% quarter-over-quarter.
- 25 funds opened new Dr. Reddy's Laboratories positions in Q2 2024 and 31 closed out, a net change of -6 holders.
- The largest Dr. Reddy's Laboratories buyer in Q2 2024 was Morgan Stanley, an estimated $82.6M added.
- The largest Dr. Reddy's Laboratories seller in Q2 2024 was Man Group, an estimated $41.9M sold.
Based on aggregated 13F filings for Q2 2024.